PerspectiveBreast Cancer

Molecular Profiling: Moving Away from Tumor Philately

See allHide authors and affiliations

Science Translational Medicine  01 Sep 2010:
Vol. 2, Issue 47, pp. 47ps43
DOI: 10.1126/scitranslmed.3001329

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Despite the remarkable enhancements in breast cancer classification and characterization, an exhaustive comprehension of the underlying carcinogenic processes and an accurate prediction of its clinical behavior are yet to be achieved. On the wave of recent scientific advances and clinical findings, new cutting-edge technologies are poised to deliver an array of diverse molecular data that are expected to dramatically alter breast cancer diagnosis and treatment.


  • Citation: J. S. Reis-Filho, B. Weigelt, D. Fumagalli, C. Sotiriou, Molecular profiling: Moving away from tumor philately. Sci. Transl. Med. 2, 47ps43 (2010).

View Full Text

Stay Connected to Science Translational Medicine